Actin polymerization and bacterial movement  by Lasa, Iñigo et al.
 .Biochimica et Biophysica Acta 1402 1998 217–228
Review
Actin polymerization and bacterial movement
Inigo Lasa a, Pierre Dehoux b, Pascale Cossart b,)˜
a Dpto. Produccion Agraria, Uni˝ersidad Publica de Na˝arra, Campus de Arrosadia srn, Pamplona 31006, Na˝arra, Spain
b Unite des Interactions Bacteries-Cellules, Institut Pasteur, 28 rue du Docteur Roux, Paris 75724, France´ ´
Received 29 September 1997; revised 5 January 1998; accepted 6 January 1998
Keywords: Actin polymerization; Bacterium; Motility
Contents
1. Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 218
2. Intracellular bacterial pathogens . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 218
3. The bacterial factors involved in the actin-based motility . . . . . . . . . . . . . . . . . . . . . . . . 219
3.1. The actA gene product of L. monocytogenes . . . . . . . . . . . . . . . . . . . . . . . . . . . . 219
3.2. The icsA gene product of S. flexneri . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 222
4. The cellular factors involved in the bacterial actin-based motility . . . . . . . . . . . . . . . . . . . 223
5. The vaccinia virus . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 224
6. Actin-based motility of extracellular bacteria . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 224
7. ActA induced actin-based motility: current hypothesis . . . . . . . . . . . . . . . . . . . . . . . . . 225
8. Conclusion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 226
Acknowledgements . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 226
References . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 226
) Corresponding author. Fax: q33-1-45-68-87-06; E-mail: pcossart@pasteur.fr
0167-4889r98r$19.00 q 1998 Elsevier Science B.V. All rights reserved.
 .PII S0167-4889 98 00009-3
( )I. Lasa et al.rBiochimica et Biophysica Acta 1402 1998 217–228218
1. Introduction
In eucaryotic cells, several important functions
such as cell motility, morphogenesis or transport of
organelles from one part of the cell to another depend
on spatially and temporally coordinated interactions
w xbetween actin and membrane compartments 1 . Actin
 .is a globular protein G-actin of 43 kDa able to
 .polymerize into long filaments F-actin . In vitro
studies have shown that actin filament assembly starts
with the formation of a thermodynamically unstable
trimer that rapidly grows into a filament by addition
w xof new monomers 2 . Interestingly, the two ends of
the actin filament differ in the critical actin monomer
concentration necessary for growth The elongation
process at the ‘barbed’ end is favored over the oppo-
w xsite ‘pointed’ end 3 . In the mammalian cell, actin is
present either as a monomer, sequestered mainly by
profilin or thymosin b4 or as actin filaments such as
those found in protrusion of lamellipodial extensions,
microvilli and stress fibers. The formation of these
structures is regulated by proteins that either se-
quester actin monomers decreasing their disponibil-
.ity , nucleate G-actin, bundle actin fibers as large
actin cables, cross-link the filaments or cap filament
w xbarbed-ends 4,5 .
The observations that in motile fibroblasts actin
filaments are organized with their barbed-ends ori-
w xented towards the leading edge 6,7 and that exten-
sion of lamellipodial protrusion involves actin fila-
w xment assembly 8 has led to the concept that rapid
polymerization of actin at the leading edge, followed
by depolymerization towards the center of the cells,
could be a driving force for pushing the membrane in
w xthe protrusions 1 . However, identification of the
molecules that regulate this process and how they
contribute to force generation are difficult to ap-
proach because the highly dynamic nature of the
process is easily altered by laboratory manipulations.
The recent discovery that certain pathogenic bacte-
w x w xria including Listeria 9,10 , Shigella 11 , Rickettsia
w x  . w x12,13 and viral pathogens vaccinia virus 14 can
be propelled in the cytoplasm of the infected cell by
an actin polymerization mechanism that resembles
aspects of protrusion at the front of motile cells has
opened a new exciting research area. The relative
simplicity of the bacterial surface compared to the
inner face of the plasma membrane and the existence
of genetic tools to manipulate these bacteria provide
a simplified model to dissect how actin dynamics can
generate the force for protrusion formation in the
appropriate place of the cell at the right moment.
2. Intracellular bacterial pathogens
Intracellular bacterial pathogens can be classified
into two groups: one group is comprised of parasites
which throughout their life cycle are present into
vacuoles e.g. Mycobacterium , Legionella ,
Salmonella, Coxiella, Chlamydia. The second group
consists of parasites that grow and replicate within
the cytoplasm e.g. Listeria, Shigella and Rickettsia.
Bacteria from the first group may migrate through
host cells using a relatively passive mechanism of
transcytosis which to our knowledge has not been
addressed. In contrast, bacteria from the second group
have developed an active mechanism of continuous
actin filament assembly at the bacterial surface that
propels the bacterium through the cytoplasm of the
infected cell.
Listeria monocytogenes is a gram-positive bacillus
responsible for food-borne infections leading to se-
vere septicemia, meningo-encephalitis and abortion in
w xpregnant women 15 . Shigella flexneri is a gram
negative bacterium closely related to Escherichia coli
and a common cause of bacillary dysentery in devel-
w xoping countries 16 . Rickettssia rickettsii and Rick-
ettsia conorii are gram negative-bacteria, obligate
intracellular parasites in contrast to Listeria and
Shigella which are facultative intracellular
. w xpathogens , responsible for spotted fevers 17 . These
three bacterial species have been separated by mil-
lions of years of evolution and the diseases they
produce have no obvious similarities. They infect
different types of cells. Yet, their interactions with
the cells of the infected host share remarkable simi-
w xlarities 18 . The infection cycle begins when these
bacteria induce their own phagocytosis by cells that
are normally non phagocytic. After entry, bacteria
secrete hemolysins andror phospholipases which dis-
rupt the phagolysosomal membrane. Once inside the
host cytoplasm, bacteria grow and divide using host
cell nutrients. Concomitantly, they start to induce the
polymerization of host cell actin around themselves.
This actin coat then rearranges into a tail located at
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one end of the bacterium which can be up to 10–20
mm in length made up of actin filaments for re-
w x.views, see Refs. 18–22 . In the case of Rickettsia,
the initial stage of bacteria surrounded by actin has
not been reported and only bacteria associated with
 .comet tails can be detected our unpublished results .
Formation of actin tails is associated with bacterial
movement with speeds ranging from 6–60 mm miny1
w x23–26 . The direction of this intracellular movement
appears random. Occasionally, bacteria make contact
with the plasma membrane producing filopod-like
projections with a single or two bacteria at their tips.
When these long pseudopods make contact with a
neighboring cell, they are rapidly phagocytosed by
the second cell, resulting in the formation of two
membrane–vacuoles that again are disrupted by the
w xaction of hemolysins and phospholipases 10,27 . This
strategy allows these bacteria to spread directly from
cell to cell and disseminate within tissues without
leaving the cytoplasm of the host cell and therefore
being protected from host defenses.
3. The bacterial factors involved in the actin-based
motility
Electron micrographs of intracellular Listeria
showed that actin filaments were immediately adja-
cent to the bacterial surface suggesting that a protein
either secreted or present on the bacterial surface was
w xresponsible for the actin polymerization activity 9 .
In addition, microinjection of live infected cells with
fluorescent monomeric actin has clearly demonstrated
that actin polymerization take places at the posterior
end of the bacteria suggesting that the bacterium has
w xan active role in the process 24 . Isolation of transpo-
son or plasmid insertion mutants unable to induce
actin polymerization allowed the identification of
w xgenes actA from L. monocytogenes 28–30 and icsA
 . w xor ˝irG from S. flexneri 11,31,32 . The gene iactA
from L. i˝ano˝ii was later isolated based on its
w xhomology with actA 33 . The gene responsible for
the actin polymerization process in Rickettsia is still
unknown.
3.1. The actA gene product of L. monocytogenes
The actA gene encodes a mature protein of 610
amino-acids, named ActA, which contains in the
center of its sequence, a very striking succession of
prolinerglutamic acid-rich repeats reminiscent of the
proline-rich region of vinculin and zyxin Figs. 1 and
.2 . ActA is asymmetrically distributed on the bacte-
rial surface with maximal amounts at one pole and
w xdecreasing concentration towards the other 34 . In
infected cells, the ActA-expressing pole co-localizes
with the site of actin assembly, suggesting that the
ActA distribution predetermines actin assembly and
movement in the direction of the non ActA-ex-
pressing pole. The mechanism underlying the asym-
metric localization is unknown but polarity seems to
be established in dividing bacteria by the lack of
incorporation of ActA at the region of septation
which then becomes the so-called new poles which
w xare then devoid of ActA 34 . There is some evidence
that polarity might increase during intracellular
 .movement our unpublished observations .
That ActA is the sole listerial protein needed for
actin-based motility was demonstrated by two types
of heterologous expression assays. In one type of
experiments, wild-type ActA was expressed by trans-
fection in mammalian cells resulting in an ActA
protein spontaneously targeted to mitochondria, which
w xbecame covered with actin filaments 35 . Similarly,
transient expression of ActA fused to a CAAX-box,
the plasma membrane anchor sequence of K-ras,
produced actin polymerization at the inner face of the
plasma membrane and changes in cell morphology
w x36 . In a second type of experiments, ActA was
either expressed in the non-pathogenic bacterium L.
w xinnocua 37 or attached on the surface of Streptococ-
w xcus pneumoniae 38 , resulting in both cases, in bac-
teria able to trigger actin assembly and movement in
Xenopus lae˝is cytoplasmic extracts. Such extracts in
which addition of rhodamine labelled actin monomers
allows visualization of the actin tails in real time,
have been very instrumental to study actin-based
w xmotility 25 .
Regions of ActA involved in the actin polymeriza-
tion process were identified either by transfection in
w xeucaryotic cells 39 or by expression in an ActA-de-
letion mutant of a series of internal deletion forms of
w xActA 40–42 . Results from these experiments indi-
cate that the central proline-rich region is not abso-
lutely essential. However, its absence results in
severely shortened tails and slower motility. In addi-
tion when each proline-rich repeat is independently
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w x w xFig. 1. Schematic representation of IcsA and ActA. Amino acids are numbered as in Ref. 29 for ActA and in Ref. 52 for IcsA. The
 .  .signal peptides SP , membrane anchor MA and the regions important for their functionality are shown. The a-domain of IcsA is
exposed on the surface of the bacteria and contains glycine-rich repeats, while the b-domain is embedded in the outer membrane. In
 .ActA, the amino-terminal domain contains all the elements necessary for the actin-based motility: region T residues 117–121 is
 .necessary for actin tail formation, region C 21–97 is necessary for the continuous actin filament elongation process and region between
amino acids 97–235 is necessary for ActA dimerization.
deleted, the phenotypic effect is proportional to the
w xnumber of repeats that are deleted 42 .
 .In contrast, the amino-terminus residue 1–234 of
ActA is essential for motility as its deletion com-
pletely abolishes actin assembly. Moreover, when the
N-terminus of ActA is fused to the v fragment of
b-galactosidase and expressed in L. monocytogenes
DActA, it induces actin assembly and movement in
Xenopus eggs extracts demonstrating that this domain
contains all the necessary elements for the actin tail
w xformation 41 . A detailed analysis of ActA variants
where small regions of the N-terminal domain were
deleted allowed the identification of two critical re-
 .gions. The first region T covering amino-acids
117–121 is critical for actin tail formation, as dele-
tion of this region or treatment of L. monocytogenes
wild type with antibodies against this region inhibits
tail formation but does not completely abolish actin
 .assembly. The second region C covering amino-
acids 21–97 is involved in maintenance of the conti-
nuity of the actin-tail formation, as deletion of this
region leads to ‘discontinuous’ comet tails in Xeno-
 . w xpus eggs extracts Figs. 1 and 3 41 .
Recent studies using the yeast two hybrid system
have suggested that ActA forms homodimers. Chemi-
cal cross-linking experiments on bacteria grown in
broth and expressing different ActA variants con-
firmed these results leading to the identification of a
region between amino acids 97–234 as being essen-
w xtial for dimerization 43 . The fact that the region in
the N-terminal domain essential for actin tail forma-
 .tion 117–121 overlaps with the region of ActA
necessary for the dimerization process strongly sug-
gests that dimerization could be directly involved in
actin polymerization.
Bacteria grown in broth do not polymerize actin
efficiently and no enzymatic activity has been associ-
ated with purified ActA, leading to the suggestion
that ActA function may occur only after modification
inside cells. To date, the only modification reported
w xfor ActA is phosphorylation 44 , however, whether
phosphorylation is required for ActA function is still
w xan open question 40 .
Sequence analysis of ActA revealed that the pro-
line-rich repeats and the carboxy-terminal domain
w xshare significant sequence similarities with zyxin 45 ,
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 .  .Fig. 2. Homologies between ActA and vinculin and zyxin. Top: ActA 630 amino acids , human vinculin 1066 amino acids and human
 .zyxin 572 amino acids are schematically represented. The N-terminal domain of ActA and the actin-binding domain of vinculin share
25% sequence identity. The proline rich region of vinculin is located just upstream of its C-terminal actin-binding domain. It has not been
aligned with ActA in this figure for clarity. The proline-rich and C-terminal domains of ActA have here been aligned with the N-terminal
part of human zyxin. Bottom: Comparison of the amino acid sequences of the N-terminal domain of ActA with the actin binding domain
of human vinculin.
an actin binding protein associated with focal con-
tacts and stress fibers. Transfection experiments with
a zyxin variant fused to a CAAX box to anchor the
protein in the inner face of the plasma membrane
revealed that zyxin triggered a similar reorganization
of actin cytoskeleton as the homologous regions of
w xActA 46 . We recently noticed that the amino-termi-
nal domain of ActA has sequence homology 25%
.identity with the C-terminal actin-binding domain of
 .  . vinculin amino acids 879–1066 Fig. 2 Pierre
.Dehoux and P. Cossart, unpublished results . Ho-
mologies with presumptive actin binding sites present
 . w x  .in caldesmon 64-LKEKAE-70 47 , villin LKKEK
w x  . w x48 and b-thymosin LKKTET 49 had previously
been noticed. Although all these homologies suggest
the presence of actin binding sites in the amino-
Fig. 3. Actin comet tails induced by wild type ActA and ActA D21–D97 in Xenopus oocytes extracts. Bacteria were incubated in
Xenopus extracts containing rhodamine–G-actin and observed by both phase contrast and fluorescence.
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terminal domain of ActA, initial attempts to demon-
w xstrate such interactions had failed 29 . In contrast,
recent in vitro experiments with synthetic peptides
corresponding to region C of the amino-terminal
 .domain of ActA residues 33–74 have demonstrated
w xthat this region, is able to bind F-actin 43 . It is
possible that this region is shielded in wild type ActA
and that region 33–74 thus represents a cryptic
actin-binding site.
Actin polymerization may not be the only function
of ActA in L. monocytogenes infection. L. monocy-
togenes DActA infects 10–20 times less efficiently
 . different types of cell lines PtK2, Vero, CaCo2 our
.unpublished results suggesting that besides its pri-
mary role in actin polymerization, ActA could be
involved in the entry process. In agreement with
w xthese observations, Alvarez-Dominguez et al. 50
have shown that host cell heparan sulfate proteogly-
cans could mediate attachment and entry of L. mono-
cytogenes and that ActA might be the bacterial ligand
involved in the recognition of the heparan sulfate
receptor. These observations deserve further investi-
gation.
3.2. The icsA gene product of S. flexneri
The icsAr˝irG gene located on the virulence
plasmid of S. flexneri encodes an outer membrane
protein of 1102 amino acids, named IcsArVirG Fig.
.1 . The protein is anchored to the outer membrane
probably by a mechanism in which the carboxy-
 .terminal domain IcsA b , residues 759–1102 forms
a b-barrel structure through which the amino-termi-
 .nal domain IcsA a , residues 53–758 is translocated
w xacross the outer membrane 51 . The IcsA a domain
contains six glycine-rich repeats of 32–34 amino
 .  .acids residues 105–307 Fig. 1 . After the anchor-
 .ing step, a specific serine protease SopA , also en-
coded by the virulence plasmid and closely related to
the proteases OmpT and OmpP of E. coli, cleaves a
 .certain proportion of the protein 25–50% , leading
w xto the secretion of the IcsA a domain 52–55 . Cleav-
age occurs between the two arginine residues within
w xthe sequence 756-SSRRASS-762 54,56 , a region
which has been described as a putative PKA phos-
w xphorylation site 57 .
IcsA, as ActA, is also asymmetrically distributed
on the bacterial surface and is localized in infected
cells at the pole of the bacterium where actin poly-
w x w xmerization occurs 53 . Recent experiments 55 sug-
gest that polar distribution of IcsA is due to an
intrinsic property of IcsA which targets the protein to
the entire bacterial surface albeit with an enhance-
ment at the pole opposite to the division septum,
probably by a mechanism linked to bacterial growth
and division, as for ActA. Then, the weak proteolytic
activity of SopA removes some of the surface ex-
posed IcsA protein reducing the amount of IcsA on
each side of the bacterium. Accordingly, a S. flexneri
DsopA strain retains its ability to accumulate actin
but is strongly affected in correct actin tail formation,
suggesting that asymmetric distribution of IcsA is
w xnecessary for actin-tail formation 56 .
Heterologous expression of IcsA in an E. coli
DompT strain allows this strain to polymerize actin
and move at speeds equivalent to that of L. monocy-
w xtogenes in Xenopus extracts 86 , demonstrating that
IcsA is sufficient to induce actin polymerization.
Surprisingly, in the same Xenopus extracts, the S.
flexneri wild-type strain is not able to polymerize
actin while a S. flexneri strain impaired in
 .lipopolysacaride LPS expression becomes sur-
rounded by actin, suggesting that modification of
LPS affects the interaction between Shigella and host
cytoplasmic components.
Regions of IcsA involved in the actin polymeriza-
tion process were identified by expression of IcsA
w xvariants in a S. flexneri DicsA 58 . These experi-
ments suggested the presence of two critical regions
in IcsA a covering residues 102–319 and residues
.320–508 but their function in the actin-tail forma-
tion process itself is still unknown.
Immunofluorescence experiments using anti-IcsA
polyclonal antibodies suggested that IcsA, in contrast
w xto ActA, is localized throughout the actin tail 53 .
However, other experiments performed to visualize
the localization of a noncleavable IcsA variant using
 .monoclonal anti-IcsA antibodies MabF15 , have
shown that the apparent presence of IcsA in the actin
tail was due to the cross reactivity of the anti-IcsA
antibodies with a still unidentified protein of 70 kDa
w xfrom the host 56 . This host protein is also localized
at the leading edge of non-infected cells and has been
proposed to be the IcsA homolog of the eucaryotic
cells.
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4. The cellular factors involved in the bacterial
actin-based motility
Many actin-binding proteins are localized to the
actin comet tails or at the posterior end of Listeria
and Shigella where actin polymerization takes place
 .Table 1 . However, detection of some of these pro-
teins in the tails may simply be a consequence of the
high F-actin density and it is probable that many of
them are not essential for the process.
In the case of Listeria, among all the identified
proteins only the Vasodilator-stimulated phosphopro-
 . w xtein VASP 61 and a murine protein from the same
 . w xfamily MENA 62 are able to bind directly to ActA
in vitro. In infected cells, VASP colocalizes with the
beginning of the actin tails. VASP is a 46–50 kDa
proline rich protein normally localized at focal con-
tacts and at the cell cortex. Besides ActA, VASP is
w x w xable to bind profilin 67 , zyxin 68 and vinculin
w x69,70 . Zyxin and vinculin also contain a proline-rich
motif, which is highly similar to the proline rich
repeats of ActA. Neither zyxin that is proposed to be
w xthe ActA homolog 45,46 , nor vinculin which in
contrast to VASP and MENA does not change its
cellular localization after microinjection of a peptide
w xfrom the proline rich region of ActA 62 , seems to
be involved in Listeria motility. In contrast, profilin,
a 15.5 kDa protein that promotes actin assembly in
the presence of free barbed ends, has, as VASP been
localized to the bacterial pole close to the tail and it
has been proposed that profilin bound to VASP could
provide polymerization-competent actin monomers,
and thereby increase the efficiency of the ActA medi-
w xated actin polymerization process 25 . However, de-
pletion of profilin in Xenopus extracts by more than
w x98% has no effect on bacterial movement 71 and
deletion of the proline-rich region of ActA that im-
paired VASP binding does not abolish actin tail
w xformation 40–42 , strongly suggesting that VASP is
important but not essential for the process.
Recently, a seven polypeptide complex isolated
from human platelets containing the two actin-related
proteins Arp2 and Arp3, and similar to a complex
w xfirst isolated from Acanthamoeba 72 was shown to
elicit actin filament accumulation on the surface of L.
w xmonocytogenes albeit without tail formation 63 . Al-
though direct interaction between Arp2 and Arp3 and
the N-terminal domain of ActA has not been demon-
strated, it might be possible that these proteins serve
as a link between ActA and actin.
ADFrcofilin, which belongs to a group of small
 .15–22 kDa actin-binding proteins that includes
cofilin, dextrin, depactin, actophorin, and actin de-
 . w xpolymerizing factor ADF 73 , was also identified
as involved in the Listeria actin-based motility. Im-
munodepletion of 75% of the endogenous
ADPrcofilin in Xenopus egg cytoplasmic extracts
results in tails five times longer than the wild type
Table 1
Actin related proteins localized to the tail or at the bacterial pole where actin polymerization takes place
Bacteria Protein Localization Interaction with IcsArActA Reference
w xListeria a-actinin tail y 23,24,59
w xTropomyosin tail y 23
w xFimbrinrplastin tail y 85
w xProfilin bacterial pole y 25
w xVinculin tail y 59
w xTalin tail y 59
w xVillin tail y 60
 . w xEzrin radixin tail y 60
w xVASP bacterial pole q 61
w xMENA bacterial pole q 62
w xComplex Arp2r3 tailrbacterial pole y 63
w xCofilin ? ? 64,65
w xShigella FimbrinrPlastin bacterial pole ? 66
w xVASP tail ? 61
w xVinculin tailrbacterial pole q 51
w xp70 tail ? 56
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counterpart and containing 15–20 fold more actin,
w xwhile movement rate is essentially unaffected 64 .
Similarly, addition of exogenous Arabidopsis ADF1
to diluted human platelet extracts causes a dramatic
enhancement of bacterial speed and a shortening of
w xthe actin tail 65 . In contrast, addition of excess of
ADF to concentrated extracts where actin monomer
concentration is not rate limiting has no effect on
movement rate. Both, the depletion and addition ex-
periments, are in agreement with the effects of
ADFrcofilin on actin filament dynamics in vitro,
where ADF increases the rate of filament turnover.
However, further experiments will be necessary to
determine whether the turnover enhancement is due
to filament severing and or to an increase in the
off-rate of ADP–actin monomer at the pointed ends.
In the case of IcsA, the 85 kDa domain a-do-
.main is able to interact with the head domain of
w xvinculin 58 a protein normally responsible for the
link between actin filaments and integrins via talin
and a-actinin, in the focal contacts.
VASP does not bind IcsA directly, but is detected
in the whole actin tail. Microinjection of peptides
corresponding to ActA proline-rich repeats FEFPPP-
.  .PTDE or to the peptide GPPPPP which is found3
in the sequence of VASP blocks Shigella movement
w xin cells 74 . Since vinculin has an ActA like
proline-rich motif, one simple explanation for this
result is that vinculin could be the cellular VASP-bi-
nding analog of ActA that would mediate the interac-
tion between IcsA and VASP. Further experiments
are needed to demonstrate that interaction between
IcsA and vinculin is necessary for actin based motil-
ity and that Shigella is impaired in its capacity to
polymerize actin in the cytoplasm of cells lacking
vinculin.
5. The vaccinia virus
Vaccinia virus, the poxvirus strain used to vaccine
against variola virus, has been shown to move within
the cytoplasm of the host cells in association with
actin tails very similar to those described for
w xpathogenic bacteria 14,75 . The morphogenesis of
vaccinia virus includes several maturation steps, but
 .only the final intracellular enveloped virus IEV
enwrapped by two membranes from the trans Golgi
network is able to induce actin-tail formation and
viral movement. This form escapes from the host cell
by fusion of the external membrane with the cellular
plasma membrane, suggesting that actin-based motil-
ity could allow the virus to reach the plasma mem-
w xbrane 76 .
The vaccinia virus has a genome of 190 kbp
encoding over 260 potential open reading frames.
However, sequence comparisons of vaccinia virus
genome with ActA, IactA and IcsA have failed to
w xidentify any ORF with significant homology 14 and
the protein responsible for the actin polymerization
has not been identified yet. It could well be a cellular
protein specifically recruited by the membrane en-
veloped virus.
Interaction between actin cytoskeleton and viral
particles is not specific to vaccinia and other viruses
including baculovirus, rabies virus, measles virus,
w xfrog virus, mouse mammary tumor virus 77 were
reported to interact with actin cytoskeleton during
viral genome transcription, virion assembly and bud-
ding.
6. Actin-based motility of extracellular bacteria
In contrast to bacteria that live inside the cyto-
plasm of the infected cell, some pathogens are able to
induce contact-mediated morphological changes in
the host cell. For example, when enteropathogenic E.
 .coli EPEC , which is one the major cause of infant
diarrhea in the developing countries, attach to the
cells of the border brush of the intestine, they induce
a rise in intracellular Ca2q, a decrease in the number
of the microvilli and accumulation of actin filaments
just underneath the EPEC surface attachment sites
 . w xthe attaching and effacing phenotype 78 . In some
cases, beneath the attached EPEC, the actin filaments
become organized into pseudopod-like structures,
w xnamed ‘pedestals’ 79 . Video microscopy has shown
that pedestals may translocate the attached EPEC
w xalong the cell surface 80 . This movement is inhib-
ited by cytochalasin D, indicating that it is actin
polymerization dependent. In contrast to the disas-
sembly effect of cytochalasin D in the actin filaments
of Listeria tails, the actin structure underlying the
EPEC is not depolymerized by cytochalasin D, an
indication of significative differences in the organiza-
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tion of both systems. Another significant difference
between the actin polymerization process induced by
intracellular and extracellular bacteria is the interposi-
tion of the cell membrane between EPEC and the
actin filaments in the pedestal, in contrast to the
direct contact between actin filaments and intra-
w xcellular bacteria 80 . In fact, EPEC really appear as a
very good model to study signal transduction leading
to cytoskeletal rearrangements, at the plasma mem-
brane
EPEC-induced actin filament assembly, and inti-
mate attachment requires insertion in the plasma
membrane of a 90 kDa protein which is then phos-
phorylated and becomes the receptor for intimin, a
w xprotein responsible for the attachment 81 . How this
mechanism triggers the cytoskeleton rearrangements
is presently unknown.
7. ActA induced actin-based motility: current hy-
pothesis
The mechanism of actin polymerization induced
by ActA is only partially understood. Several lines of
evidence suggest that ActA is not directly responsible
for the actin polymerization, and that recruitment of
different proteins by ActA in the vicinity of the
bacterium could generate the appropriate conditions
for actin tail formation. In this context, we propose a
 .model Fig. 4 for actin tail formation divided into
 .three phases: i in a first step, free barbed ends are
generated by either uncapping or severing of preexist-
ing actin filaments or by nucleating actin monomers.
The role of the N-terminal domain of ActA in this
 .process is unknown. ii The second step is the
elongation of actin filaments at the free barbed-ends
generated in the first step, leading to bacterial propul-
sion. The VASP–profilin complex bound to the cen-
tral proline rich region of ActA could provide poly-
merization-competent actin monomers to the amino-
terminal domain and increase the efficiency of actin
polymerization process. Whether and how the
Arp2rArp3 complex mediate binding of actin to
 .ActA remains to be established. iii In the last step,
actin filaments are capped, released and cross-linked
to the performed tail. Cross-linking of actin filaments
in the actin tail is important for movement as shown
by the arrest of bacterial movement after microinjec-
Fig. 4. Hypothetical model of actin assembly by ActA dimer.
ActA is represented as a dimer. The proline-rich region of ActA
interacts with the VASP-profilin complex thought to fuel poly-
merization competent actin monomers in the vicinity of the
bacterium. Actin polymerization starts by the generation of free
barbed ends either by nucleation, severing or uncapping of
F-actin filaments. Then, elongation proceeds until release, cap-
ping and cross-linking occur while a tail is formed for details,
.see text .
tion of a proteolytic fragment of a-actinin that acts as
w xa dominant negative protein 59 .
Bacterial movement is probably due to the elonga-
tion of a critical number of actin filaments. In bacte-
ria expressing wild-type ActA the speed of move-
ment appears continuous, over short periods of time,
because the number of filaments lost for the elonga-
tion process by capping are continuously replaced by
new filaments. In contrast, the discontinuous actin
tail phenotype of D21–D97 ActA mutant Figs. 3
.and 4 could be explained by a capping process of the
newly generated free barbed ends, occurring more
rapidly than in the wild type. Since the rate of
nucleation is not expected to vary over short inter-
vals, the generation of new free barbed ends in the
mutant cannot overcome the loss of free barbed ends
due to rapid capping. Consequently, when the num-
ber of uncapped filaments implicated in the elonga-
tion process is insufficient to propel the bacteria, the
 .speed of movement decreases Fig. 3 . Meanwhile,
ActA continues to generate new free barbed ends
until accumulation of a critical number is reached.
( )I. Lasa et al.rBiochimica et Biophysica Acta 1402 1998 217–228226
Elongation at the free barbed ends can then propel
the bacteria at high speed, but unprotected filaments
are being capped again and a new cycle begins. This
model strongly suggests that the N-terminal domain
of ActA may play a critical role in protecting barbed
ends from capping proteins. When integrity of this
N-terminal domain is impaired, capping occurs very
rapidly. Such a role for ActA—protection against
capping proteins—suggests that ActA would bind
actin. While peptides derived from ActA have clearly
w xbeen shown to bind actin 43 , it is not the case for
ActA. Whether this protein contains a cryptic binding
site is still an open question.
The role of capping proteins has recently also been
w xdiscussed by Sechi et al. 82 who have demonstrated
that the Listeria-induced actin tail, in contrast to
w xprevious reports 9,83,84 , has, at least in the protru-
sions, a core of parallel long axial filaments trans-
versed by randomly oriented, short filaments that
decrease in abundance from the head to the end of
the tail. To explain these two types of actin filaments,
the authors propose that there is a region close to the
bacteria where filaments are protected from capping
proteins. The length of the filaments would depend
on the length of time spent by these filaments in this
protected region, which itself would depend on the
orientation of the filaments with respect to the bacte-
rial body. Filaments oriented tangentially to the poly-
merization zone lie outside from the protected region
and generate the short oblique and capped filaments
of the tail. Other filaments that are nucleated with an
axial orientation, with respect to the bacterial body,
maintain their barbed ends in the polymerization zone
for an extended time and grow longer. Whether these
interpretations are correct and whether tails in the
cytoplasm are also made of two populations of actin
filaments probably deserves more investigation.
Intriguingly, depletion of gelsolin, a barbed-end
capping and F-actin severing protein does not affect
w xtail length or movement 64 , but one cannot exclude
that other capping proteins might be involved in the
capping process.
8. Conclusion
In conclusion, our knowledge of the factors in-
volved in actin-based motility is improving but the
phenomenon remains quite enigmatic and several
questions are still to be addressed: what are all the
host proteins necessary for the process? Is ActA
dimerization important for activity? How does the
amino-terminal domain of ActA generate free barbed
ends? Are bacteria linked to the comet tail? What is
the minimal number of free barbed ends needed for
movement? What is the maximal force that actin
polymerization could generate? Is the ActA induced-
actin polymerization process regulated by the same
mechanisms that those which regulate actin dynamics
in host cells? Clearly, actin polymerization is a com-
plex phenomenon and many points which have not
been discussed here, will have to be considered, e.g.
the role of the signalling molecules or ions such as
phosphoinositides or Ca2q ions.
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